Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer. [electronic resource]
Producer: 20160513Description: 1223-1229 p. digitalISSN:- 1569-8041
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- enzymology
- Chemoradiotherapy -- adverse effects
- Cisplatin -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Everolimus -- administration & dosage
- Female
- France
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- enzymology
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Protein Kinase Inhibitors -- administration & dosage
- Radiotherapy Dosage
- Radiotherapy, Conformal -- adverse effects
- Risk Factors
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Time Factors
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.